The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Hypoxia-regulated target genes implicated in tumor metastasis
Open accessAbstract
Hypoxia is an important microenvironmental factor that induces cancer metastasis. Hypoxia/hypoxia-inducible factor-1α (HIF-1α) regulates many important steps of the metastatic processes, especially epithelial-mesenchymal transition (EMT) that is one of the crucial mechanisms to cause early stage of tumor metastasis. To have a better understanding of the mechanism of hypoxia-regulated metastasis, various hypoxia/HIF-1α-regulated target genes are categorized into different classes including transcription factors, histone modifiers, enzymes, receptors, kinases, small GTPases, transporters, adhesion molecules, surface molecules, membrane proteins, and microRNAs. Different roles of these target genes are described with regards to their relationship to hypoxia-induced metastasis. We hope that this review will provide a framework for further exploration of hypoxia/HIF-1α-regulated target genes and a comprehensive view of the metastatic picture induced by hypoxia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, iron regulates the activity of the transcription factors NF-κB and HIF-1α [58], which promote the expression of genes involved in the survival and metastasis of cancer cells [59, 60].”
From The utility of iron chelators in the management of inflammatory disorders (2015) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
RetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Cited by
Sorted by citations
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Regulation of pyruvate metabolism and human disease
Gray, L. R., Tompkins, S. C., & Taylor, E. B. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1539-2 · Cited by 990
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 988
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 816
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1769-9 · Cited by 560
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 546
Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13092053 · Cited by 489
González-Ávila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., García-Hernández, A. A., & Falfán‐Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 393
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., Luca, R. D., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 355
Pathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Tam, S. Y., Wu, V., & Law, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 319
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 284
Ren, D., Yang, Q., Dai, Y., Guo, W., Du, H., Song, L., & Peng, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0688-6 · Cited by 238
Targeting the Redox Balance in Inflammatory Skin Conditions
Wagener, F. A. D. T. G., Carels, C. E. L., & Lundvig, D. M. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059126 · Cited by 223
Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression
Shih, J.-W., Chiang, W.-F., Wu, A. T. H., Wu, M., Wang, L., Yu, Y., Hung, Y., Wang, W., Chu, C.-Y., Hung, C.-L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15874 · Cited by 216
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
Jahanban‐Esfahlan, R., de la Guardia, M., Ahmadi, D., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25859 · Cited by 201
Young, V. J., Brown, J. K., Maybin, J. A., Saunders, P. T. K., Duncan, W. C., & Horne, A. W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1026 · Cited by 168
Pizzini, S., Bisognin, A., Mandruzzato, S., Biasiolo, M., Facciolli, A., Perilli, L., Rossi, E. M. C., Esposito, G., Rugge, M., Pilati, P., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-589 · Cited by 167
Yang, S., Wu, C., XIONG, Z.-F., & Fang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3689 · Cited by 167
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 148
Mechanisms of Regulated Cell Death: Current Perspectives
Santagostino, S. F., Assenmacher, C., Tarrant, J. C., Adedeji, A. O., & Radaelli, E. (2021) · Veterinary Pathology · doi:10.1177/03009858211005537 · Cited by 137
Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas
Gibbons, D. L., & Creighton, C. J. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24485 · Cited by 128
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
Tiana, M., Acosta‐Iborra, B., Puente-Santamaría, L., Hernansanz‐Agustín, P., Worsley-Hunt, R., Masson, N., Rio, F. G., Mole, D. R., Ratcliffe, P. J., Wasserman, W. W., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx951 · Cited by 124
Matrix Metalloproteinases’ Role in Tumor Microenvironment
González-Ávila, G., Sommer, B., García-Hernández, A. A., & Ramos, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40146-7_5 · Cited by 127
The wonders of 2‐deoxy‐ d ‐glucose
Xi, H., Kurtoğlu, M., & Lampidis, T. J. (2014) · IUBMB Life · doi:10.1002/iub.1251 · Cited by 123
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
Doktorová, H., Hraběta, J., Khalil, M. A., & Eckschlager, T. (2015) · Biomedical Papers · doi:10.5507/bp.2015.025 · Cited by 122
Hypoxia-Inducible lncRNA-AK058003 Promotes Gastric Cancer Metastasis by Targeting γ-Synuclein
Wang, Y., Liu, X., Zhang, H., Sun, L. J., Zhou, Y., Jin, H., Zhang, H., Zhang, H., Liu, J., Guo, H., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.10.008 · Cited by 112
Self-citationInside the hypoxic tumour: reprogramming of the DDR and radioresistance
Begg, K., & Tavassoli, M. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00311-0 · Cited by 109
Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer
Nesbitt, H., Sheng, Y., Kamila, S., Logan, K. A., Thomas, K. G., Callan, B., Taylor, M., Love, M., O’Rourke, D. M., Kelly, P., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.018 · Cited by 108
18F-Fluoromisonidazole in tumor hypoxia imaging
Xu, Z., Li, X., Zou, H., Sun, X., & Shen, B. (2017) · Oncotarget · doi:10.18632/oncotarget.21662 · Cited by 91
Cancer cells remodel themselves and vasculature to overcome the endothelial barrier
Shenoy, A. K., & Lu, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.031 · Cited by 89
Chen, F., Zhang, Y., Gibbons, D. L., Deneen, B., Kwiatkowski, D. J., Ittmann, M., & Creighton, C. J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3378 · Cited by 87
Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity
Terry, S., Zaarour, R. F., Venkatesh, G. H., Francis, A., El‐Sayed, W., Buart, S., Bravo, P. E., Thiery, J., & Chouaïb, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103044 · Cited by 88
Li, S., Zhang, J., Yang, H., Wu, C., Dang, X., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep12410 · Cited by 84
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Khouzam, R. A., Venkatesh, G. H., Zaarour, R. F., Chamseddine, A. N., Francis, A., Buart, S., Terry, S., & Chouaïb, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.003 · Cited by 84
Xin, X., Kumar, V., Lin, F., Kumar, V., Bhattarai, R. S., Bhatt, V. R., Tan, C., & Mahato, R. I. (2020) · Science Advances · doi:10.1126/sciadv.abd6764 · Cited by 80
Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT
Zuo, J., Wen, J., Lei, M., Wen, M., Li, S., Lv, X., Luo, Z., & Wen, G. (2016) · Medical Oncology · doi:10.1007/s12032-015-0716-6 · Cited by 78
Swartz, J. E., Pothen, A. J., Stegeman, I., Willems, S. M., & Grolman, W. (2015) · Cancer Medicine · doi:10.1002/cam4.460 · Cited by 78
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Das, P. K., Pillai, S., Rakib, M. A., Khanam, J. A., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09942-y · Cited by 78
Verduzco, D., Lloyd, M. C., Xu, L., Ibrahim‐Hashim, A., Balagurunathan, Y., Gatenby, R. A., & Gillies, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120958 · Cited by 75
Qu, A., Du, L., Yang, Y., Liu, H., Li, J., Wang, L., Liu, Y., Dong, Z., Zhang, X., Jiang, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090952 · Cited by 73
RetractedTian, P., Xu, Z., Guo, J., Zhao, J., Chen, W., Huang, W., Wang, M., Mi, C., Zhang, Y., Yang, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103073 · Cited by 71
López-Codony, V., & Tavassoli, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101017 · Cited by 73
Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine
Muscari, C., Giordano, E., Bonafè, F., Govoni, M., Pasini, A., & Guarnieri, C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-63 · Cited by 67
HIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 72
Chen, L., Shi, Y. X., Yuan, J., Han, Y., Qin, R., Wu, Q., Jia, B., Wei, B., Wei, L., Dai, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090678 · Cited by 66
COX‐1 Inhibitors: Beyond Structure Toward Therapy
Vitale, P., Panella, A., Scilimati, A., & Perrone, M. G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21389 · Cited by 66
Wang, X., Dai, X., Zhang, X., Ma, C., Li, X., Xu, T., & Lan, Q. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36549 · Cited by 66
Chen, X., Zhang, S., Wang, Z., Wang, F., Cao, X., Wu, Q., Zhao, C., Ma, H., Ye, F., Wang, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0787-2 · Cited by 65
Kim, Y. S., Lee, H.-A., Lim, J. Y., Kim, Y., Jung, C.-H., Yoo, S.-H., & Kim, Y. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.006 · Cited by 65
Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes
Kao, S.-H., Wu, K., & Lee, W. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020024 · Cited by 64
Self-citationHypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 58
Bhatia, N., Gupta, P., Singh, B., & Koul, A. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1087040 · Cited by 55
MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells
Costa, V., Dico, A. L., Rizzo, A. G., Raiata, F., Tripodi, M., Alessandro, R., & Conigliaro, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14464 · Cited by 55
Teo, Z. Q., Sng, M. K., Chan, J. S. K., Lim, M. M. K., Li, Y., Li, L., Phua, T., Lee, J. Y. H., Tan, Z., Zhu, P., et al. (2017) · Oncogene · doi:10.1038/onc.2017.244 · Cited by 55
The utility of iron chelators in the management of inflammatory disorders
Lehmann, C., Islam, S., Jarosch, S., Zhou, J., Hoskin, D., Greenshields, A., Al-Banna, N., Sharawy, N., Sczcesniak, A., Kelly, M., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/516740 · Cited by 54
Pan-urologic cancer genomic subtypes that transcend tissue of origin
Chen, F., Zhang, Y., Bossé, D., Lalani, A. A., Hakimi, A. A., Hsieh, J. J.-D., Choueiri, T. K., Gibbons, D. L., Ittmann, M., & Creighton, C. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00289-x · Cited by 57
Weidle, U. H., Birzele, F., & Nopora, A. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20116 · Cited by 52
Zhang, X., Cheng, Q., Yin, H., & Yang, G. S. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4025 · Cited by 55
Chou, C.-C., Chuang, H.-C., Salunke, S. B., Kulp, S. K., & Chen, C.-S. (2015) · Oncotarget · doi:10.18632/oncotarget.3186 · Cited by 50
Loo, S. Y., Hirpara, J. L., Pandey, V., Tan, T. Z., Yap, C. T., Lobie, P. E., Thiery, J. P., Goh, B. C., Pervaiz, S., Clement, M., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6524 · Cited by 49
Chen, Z., Liu, X., Mei, Z., Wang, Z., & Xiao, W. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00718-13 · Cited by 48
Ha, J. H., Ward, J. D., Radhakrishnan, R., Jayaraman, M., Song, Y. S., & Dhanasekaran, D. N. (2016) · Oncotarget · doi:10.18632/oncotarget.9224 · Cited by 48
Park, J., Yoon, J., & Park, B. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.10.010 · Cited by 46
Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6
Xu, X., Ge, S., Jia, R., Zhou, Y., Song, X., Zhang, H., & Fan, X. (2015) · Oncology Reports · doi:10.3892/or.2015.3900 · Cited by 45
Seo, Y., Kim, Y. S., Lee, K. E., Park, T. H., & Kim, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176851 · Cited by 45
Chen, J., Li, T., Liu, Q., Jiao, H., Yang, W., Liu, X., & Huo, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091842 · Cited by 44
Liu, L., Liu, W., Wang, L., Zhu, T., Zhong, J., & Xie, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.7223 · Cited by 42
Chan, S. T. S., Patel, P., Ransom, T. R., Henrich, C. J., McKee, T. C., Goey, A. K. L., Cook, K. M., Figg, W. D., McMahon, J. B., Schnermann, M. J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b02156 · Cited by 41
HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer
Sun, Y., Guan, Z., Liang, L., Cheng, Y., Zhou, J., Li, J., & XU, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4536 · Cited by 41
Li, Z., Ning, F., Wang, C., Yu, H., Ma, Q., & Sun, Y. (2021) · Nanoscale · doi:10.1039/d1nr03387e · Cited by 39
Tajaldini, M., Poorkhani, A., Amiriani, T., Amiriani, A., Javid, H., Aref, P., Ahmadi, F., Sadani, S., & Khori, V. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175991 · Cited by 38
Hyuga, S., Wada, H., Eguchi, H., Otsuru, T., Iwgami, Y., Yamada, D., Noda, T., Asaoka, T., Kawamoto, K., Gotoh, K., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4098 · Cited by 38
Ways into Understanding HIF Inhibition
Schönberger, T., Fandrey, J., & Prost-Fingerle, K. (2021) · Cancers · doi:10.3390/cancers13010159 · Cited by 39
Karsy, M. J., Guan, J., Jensen, R. L., Huang, E. L., & Colman, H. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.12.032 · Cited by 40
Zhang, K., Xu, P., Sowers, J. L., Machuca, D. F., Mirfattah, B., Herring, J. L., Tang, H. R., Chen, Y., Tian, B., Brasier, A. R., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000154 · Cited by 37
Single measurement of hemoglobin predicts outcome of HCC patients
Finkelmeier, F., Bettinger, D., Köberle, V., Schultheiß, M., Zeuzem, S., Kronenberger, B., Piiper, A., & Waidmann, O. (2013) · Medical Oncology · doi:10.1007/s12032-013-0806-2 · Cited by 36
Mahdi, A., Darvishi, B., Majidzadeh‐A, K., Salehi, M., & Farahmand, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27414 · Cited by 38
Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction
Rezaeeyazdi, M., Colombani, T., Eggermont, L. J., & Bencherif, S. A. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100207 · Cited by 35
Abdullah, N. A., Hashim, N. F. M., Ammar, A., & Zakuan, N. M. (2021) · Molecules · doi:10.3390/molecules26040775 · Cited by 34
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., & Wielockx, B. (2021) · Cancers · doi:10.3390/cancers13050988 · Cited by 35
Seo, J., Kim, K.-S., Park, J., Cho, J., Chang, H., Fukuda, J., Hong, K. Y., & Chun, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120622 · Cited by 33
Young, V. J., Ahmad, S. F., Brown, J. K., Duncan, W. C., & Horne, A. W. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw045 · Cited by 33
Long noncoding RNA BC 005927 upregulates EPHB 4 and promotes gastric cancer metastasis under hypoxia
Liu, X., Yf, W., Sun, L. J., Min, J., Liu, J., Chen, D., Zhang, H., Zhang, H., Zhang, H., Zhou, Y., et al. (2018) · Cancer Science · doi:10.1111/cas.13519 · Cited by 33
Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo
Luo, Z., Bai, M., Xiao, X., Zhang, W., Liu, X., Yang, X., Li, S., Huan, Y., Wu, Z., Zhang, X., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.009 · Cited by 32
The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
Lüneburg, N., Harbaum, L., & Hennigs, J. K. (2014) · BioMed Research International · doi:10.1155/2014/501612 · Cited by 32
miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell.
Ding, L., Zhao, L., Chen, W., Liu, T., Li, Z., & Li, X. (2015) · PubMed Central · Cited by 32
Jian, H., Liu, B., & Zhang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1651-4 · Cited by 32
Noncoding RNAs in Tumor Epithelial‐to‐Mesenchymal Transition
Lin, C.-W., Lin, P.-Y., & Yang, P. (2016) · Stem Cells International · doi:10.1155/2016/2732705 · Cited by 32
Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound
Park, K., Lee, H., Lee, S. H., Lee, D., Lee, T., & Lee, Y. M. (2016) · Oncotarget · doi:10.18632/oncotarget.13955 · Cited by 33
Ren, Y., Hao, P., Law, S. K. A., & Sze, S. K. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.038505 · Cited by 30
Gallardo‐Pérez, J. C., Rivero-Segura, N. A., Marín‐Hernández, Á., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.013 · Cited by 30
KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis
Sanghrajka, R. M., Koche, R. P., Medrano, H., Nagar, S. E., Stephen, D. N., Lao, Z., Bayin, N. S., Ge, K., & Joyner, A. L. (2023) · iScience · doi:10.1016/j.isci.2023.107831 · Cited by 29
Immunotherapeutic Targeting of Tumor-Associated Blood Vessels
Fabian, K. P., & Storkus, W. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_13 · Cited by 29
Targeting energy metabolism to eliminate cancer cells
Shahruzaman, S. H., Fakurazi, S., & Maniam, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167424 · Cited by 29
Kim, Y.-J., Zhao, Y., Myung, J. K., Yi, J. M., Kim, M., & Lee, S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109996 · Cited by 28
Zuo, X., Li, L., & Sun, L. V. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1808679 · Cited by 27
Li, Y., Zhang, W., Li, S., & Tu, C. (2016) · SpringerPlus · doi:10.1186/s40064-016-3064-x · Cited by 27
Nesbitt, H., Byrne, N. M., Williams, S. N., Ming, L., Worthington, J., Errington, R. J., Patterson, L. H., Smith, P. J., McKEOWN, S. R., & McKenna, D. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1361 · Cited by 26
Metadata
- Authors
- Tsai, Y.-P., & Wu, K.-J.
- Affiliations
- National Yang Ming University (TW)
- Corresponding author
- Wu, Kou-Juey
- ORCID
- Wu, Kou-Juey
- Venue
- Journal of Biomedical Science
- Published
- 2012
- Volume
- 19
- Issue
- 1
- Pages
- 102
- ISSN
- 1021-7770 (ISSN-L)
- 1423-0127
- PMC
- PMC3541338
- OpenAlex
- W2120227239
- Cited by
- 190
- References
- 85
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 9 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 11 · 2018: 16 · 2017: 22 · 2016: 19 · 2015: 24 · 2014: 24 · 2013: 16
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Journal of Biomedical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Council (DOH101-TD-C-111-007)
- National Health Research Institutes (NHRI-EX101-9931BI)
- National Research Program for Biopharmaceuticals (NSC101-2325-B-010-004)
- Taichung Veterans General Hospital
- Taipei Veterans General Hospital (DOH101-TD-C-111-007)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, HIF-1α, metastasis, epithelial-mesenchymal transition, transcription factors, histone modifiers, microRNA, small GTPases, adhesion molecules, kinases, receptors, tumor microenvironment
- MeSH terms
- Humans, Neoplasm Metastasis, Neoplasms, Transcription Factors, Transcription, Genetic, Signal Transduction, Cell Hypoxia, MicroRNAs, Hypoxia-Inducible Factor 1, alpha Subunit, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review